Current issues in hepatocellular carcinoma

Current issues highlight some of the latest research into hepatocellular carcinoma, new therapies becoming available and new drug treatments coming to the market.

Sorafenib gives new hope for patients with liver cancer At the recent 2007 American Society of Clinical Oncology meeting in Chicago, data were presented of a clinical trial in which patients with advanced primary liver cancer (hepatocellular carcinoma)...
Cis-platin gel injections demonstrate responses in primary liver cancer (Hepatocellular Carcinoma) For as many as 80% of patients with hepatocellular carcinoma, the disease is beyond operation. Intradose injectable gel, consists of the chemotherapy agent cis-paltinum and the vasoconstrictor...
Hepatitis B Vaccine and the prevetion of Hepatocellular Carcinoma Smith Kline Beecham have announced their hepatitis B vaccine recombinant (Engerix B) and claimed it to be the first anti-cancer vaccine. Whilst this claim may be thought to be unjustified by most...